Definium Therapeutics 宣布,其药物 DT120 Odt 在一项临床研究中展现出总体良好的耐受性。研究未发现任何新的安全性信号,其中尤为关键的是,没有监测到自杀倾向相关的信号。
Definium Therapeutics 宣布,其药物 DT120 Odt 在一项临床研究中展现出总体良好的耐受性。研究未发现任何新的安全性信号,其中尤为关键的是,没有监测到自杀倾向相关的信号。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.